Adiponectin may modify the risk of Barrett's esophagus in patients with gastroesophageal reflux disease

LM Almers, JE Graham, PJ Havel, DA Corley - Clinical Gastroenterology …, 2015 - Elsevier
Background & Aims Abdominal obesity and increasing body mass index are risk factors for
esophageal adenocarcinoma and its main precursor, Barrett's esophagus; however, there …
被引用次数：25 相关文章

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.

LM Almers, JE Graham, PJ Havel… - … and hepatology: the …, 2015 - escholarship.org
Background & aimsAbdominal obesity and increasing body mass index are risk factors for
esophageal adenocarcinoma and its main precursor, Barrett's esophagus; however, there …

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease

LM Almers, JE Graham, PJ Havel, DA Corley - Clinical Gastroenterology …, 2015 - infona.pl
Abdominal obesity and increasing body mass index are risk factors for esophageal
adenocarcinoma and its main precursor, Barrett's esophagus; however, there are no known …
[PDF] core.ac.uk

[PDF][PDF] Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With

LM Almers, JE Graham, PJ Havel - … : the official clinical practice journal of …, 2015 - core.ac.uk
BACKGROUND & AIMS: Abdominal obesity and increasing body mass index are risk factors
for esophageal adenocarcinoma and its main precursor, Barrett's esophagus; however …

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.

LM Almers, JE Graham, PJ Havel… - … and Hepatology: the …, 2015 - europepmc.org
Methods We conducted a case-control study evaluating the associations between
adiponectin (total, high-molecular-weight, and low-/medium-molecular-weight) and Barrett's …
[HTML] nih.gov

[HTML][HTML] Adiponectin may modify the risk of Barrett's esophagus in patients with gastroesophageal reflux disease

LM Almers, JE Graham, PJ Havel… - … and hepatology: the …, 2015 - ncbi.nlm.nih.gov
Methods We conducted a case-control study evaluating the associations between
adiponectin (total, high molecular weight, and low/medium molecular weight) and Barrett's …

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease

LM Almers, JE Graham, PJ Havel… - … and hepatology: the …, 2015 - pubmed.ncbi.nlm.nih.gov
Background & aims Abdominal obesity and increasing body mass index are risk factors for
esophageal adenocarcinoma and its main precursor, Barrett's esophagus; however, there …

Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease

LM Almers, JE Graham, PJ Havel… - Clinical Gastroenterology …, 2015 - cghjournal.org
Background & Aims Abdominal obesity and increasing body mass index are risk factors for
esophageal adenocarcinoma and its main precursor, Barrett's esophagus; however, there …